| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.0M | -68.0% | -82.2% |
| R&D Expense | $15.3M | +14.9% | -28.4% |
| SG&A Expense | $6.4M | -2.9% | -19.2% |
| Operating Income | -$15.8M | -1126.1% | -483.6% |
| Pre-tax Income | -$14.2M | — | -344.5% |
| Income Tax | $58K | -7.9% | -4.9% |
| Net Income | -$14.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $34.2M | -30.3% | -15.8% |
| Accounts Receivable | $1.6M | -12.8% | -51.4% |
| Current Assets | $149.2M | -9.4% | +20.2% |
| Total Assets | $158.3M | -9.6% | +13.9% |
| Current Liabilities | $41.0M | +4.6% | -65.6% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$52.3M | — | — |
| Capital Expenditures | $19K | — | — |
| Investing Cash Flow | -$45.3M | — | — |
| Financing Cash Flow | $93.8M | — | — |
| Free Cash Flow | -$52.4M | — | — |
| -348.1% |
| $50.9M |
| -7.8% |
| -68.7% |
| Stockholders' Equity | $107.4M | -10.4% | +557.9% |